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Natural product biosynthetic pathways often share similar architecture even when they lead to different 
final products. In polyketide synthase (PKS) and non-ribosomal peptide synthetase (NRPS) enzymatic 
pathways, the substrate is attached to a carrier protein (CP) while the tailoring enzymes make 
modifications to yield a final product. The CP may therefore have a role in determining what enzymes 
act on the substrate, influencing the final product’s chemistry. In this study, pyrrole halogenases from 
several different bacterial species were characterized in vitro to test their ability to halogenate pyrrolyl 
CPs from four different natural product biosynthetic pathways. The reactions were analyzed via mass 
spectrometry to determine the halogenation state of the products formed. This study concludes that 
only some halogenases can act promiscuously on CPs from other pathways. Additionally, there is some 
modulation in the number of halogenation events between certain CP and halogenase pairs. The 
selectivity of these halogenase and CP interactions is likely caused by protein-protein interactions, and 




Natural products are small molecule metabolites from biological sources. They are found in all parts of 
the biosphere and have a diverse range of function in ecosystems. Organisms use these molecules for 
signaling, for chemical defense, and as allelochemicals (1-3). In addition to their functional diversity, 
their chemical diversity is pronounced. This has led to their use as drug candidates with action against 
tumors, inflammation, viruses, and bacteria (4, 5). Detailed understanding of natural product 
biosynthesis will allow us to more fully understand their natural role, as well as provide a platform for 
industrial production of complex chemical structures that are otherwise too expensive to be made from 
a chemical synthesis route (6). 
 
There are some natural product pathways that share remarkably similar enzymatic machinery, including 
fatty acid synthesis (FAS), polyketide synthesis (PKS), and non-ribosomal peptide synthesis (NRPS). Each 
of these pathways takes small molecule building blocks and arranges them in modular structures to 
form highly complex final products. Through this strategy, organisms can take simple molecules like 
malonyl-CoA or amino acids and make specialized compounds for any number of purposes. The modular 
structure is facilitated by an assembly line layout of enzymes, with different enzymes carrying out 
specific modifications, then passing the growing product onwards. In most currently known pathways of 
this type, there is a CP that covalently binds the substrate while it is being modified by the other 
enzymes in the pathway. These CPs interact with the surfaces of other enzymes in a dynamic way, 
potentially helping to guide the substrate through the biosynthetic pathway (7).  
 
Several similar natural product biosynthetic pathways that utilize the same general enzymology have 
been well characterized. For one specific motif, the halogenated pyrrole, there are at least four 
pathways leading to its production (Figure 1). The biosynthesis of pyoluteorin, an antifungal molecule 
with a chlorinated pyrrole, is encoded by the Plt gene cluster in Pseudomonas fluorescence, a soil 
bacterium (8). Similarly, the biosynthesis of chlorizidine A and its chlorinated pyrrole procedes by a 
polyketide synthase gene cluster (9). However, instead of being synthesized by a terrestrial microbe, this 
set of enzymes comes from the marine bacterium Streptomyces sp. CNH-287. Marinopyrrole is also from 
a marine bacterium (10). In addition to chlorinated pyrrole rings, brominated pyrrole products like 
tetrabromopyrrole are produced by the marine bacterium Marinomonas mediterranae MMB-1 (11). 
These examples, shown in Figure 1, show that enzymology for generation of a pyrrole scaffold is 
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widespread in bacteria from a variety of environments, which makes it a natural target for biochemical 
investigation.  
 
The halogenated pyrrole biosynthesis starts with a free proline molecule (Figure 1). The proline is 
adenylated by the adenylation domain, using up ATP to attach an AMP moiety in place of the carboxyl 
group. Then, the adenylation domain attaches the proline to the pantetheine arm of the CP using AMP 
as the leaving group. This leaves a proline attached to the CP via a thioester bond. The proline is then 
dehydrogenated at two locations on the ring, generating the pyrrole. After that, the pyrrole ring is 
halogenated by the halogenase enzyme. The halogenated pyrrole ring is then further modified and 
incorporated into the final natural product structure, such as chlorizidine A or pyoluteorin. 
 
Since these pathways are well characterized, they can be used to query the selectivity of CPs and 
halogenases. Using in vitro enzyme assays, this study combined CPs and halogenases across pathways in 
an attempt to generate halogenated pyrrole products. This experiment will inform on the selectivity of 
CPs towards their respective halogenases. Additionally, it will provide a new platform for developing 
cross-pathway natural products with novel chemistries, potentially harnessing pathways from diverse 
organisms to develop novel therapeutic molecules.  
 




Each of the proteins needed for the enzymatic assay was expressed recombinantly in E. coli using 
plasmids (Table 1). The halogenase enzymes Bmp2, Clz5, and Mpy16 were expressed to encode for His-
MBP tag at their N-terminus using pET-28MBP vector. PltA halogenase was expressed to encode for His-
tagged protein using the pET-28b vector. The CPs (Bmp1, PltL, Clz18, and Mpy15) were expressed with 
His tags using the pET-28b vector. PtdH, a phosphite dehydrogenase used to regenerate NADH cofactor 
was purified previously for other experiments, and it was used from a stock kept at -80°C.  
 
Using E. coli cells transformed with the required plasmids, overnight cultures were grown at 37°C. One-
liter cultures of TB liquid media were inoculated and allowed to reach 0.6 OD600 at 37°C. Recombinant 
protein expression was induced by 0.3 mM IPTG at 18°C for 18 hours with vigorous shaking. The culture 
was then centrifuged to collect the biomass in the pellet, which was resuspended in binding buffer (see 
Table 2 for all buffer compositions). The resuspended cells were sonicated for 15 minutes with stirring 
using a 10:50 on:off cycle, lysing the cells. After the cells were lysed, the solution was centrifuged at 
13,500 rpm for 40 minutes to obtain supernatant. The supernatant was loaded onto a Nickel affinity 
chromatography column attached to an AKTA Prime FPLC system at 4°C and washed with 40 mL wash 
buffer. The protein was eluted with a 40 mL gradient of elution buffer ranging from 0% to 100%. 
Proteins were then dialyzed using dialysis buffer overnight. After dialysis, the protein solution was 
loaded onto an anion exchange column. The column was washed and the protein was eluted using IEX 
buffer B. Finally, the protein was put through a size exclusion PD-10 column for desalting and was eluted 
with storage buffer. 
 
Synthesis of pyrrolyl-CP substrates 
 
Proteins were stored at -80°C until they were ready to be used in an assay, at which point they were 
thawed on ice, vortexed gently, and centrifuged. Pyrrolyl-CP substrates were generated using purified 
CPs and organically synthesized pyrrolyl-pantetheine substrate. Multiple enzymatic transformations lead 
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to the pyrrolylpantetheine present in the biosynthetic pathway (shown in Figure 2). In this study, 
however, a pyrrole moiety was synthetically attached to a pantetheine molecule and this was 
enzymatically ligated to the CP using CoaA, CoaD, CoaE, and Sfp in a single pot reaction (Table 3) 
following the methods described previously (12). The Coa enzymes are naturally used in E. coli to 
prepare CP pantetheine groups, but they are promiscuous enough to accept a variety of altered 
pantetheine derivatives, including the pyrrolylpantetheine. The reaction products were purified on a 
Superdex 75 16/200 size exclusion chromatography column, equilibrated with 20 mM Tris-HCl (pH 8.0). 




The setup for enzyme assays is shown in Table 4. Assays were carried out in 100 μL reaction volumes 
held at 30°C for 3 hours. Each reaction contained 50 μM pyrrolyl-CP, 20 μM halogenase, 10 μM PtdH 
phosphite dehydrogenase, and 20 μM RebF flavin reductase, 20 mM HEPES buffer at pH 7.9, 200 mM 
KCl or KBr as a halide source, 1 mM NAD+, 100 μM FAD, 10 mM sodium phosphite, 5 mM TCEP reducing 
agent, and final volume adjustment was done with 20% glycerol. Freshly prepared sodium phosphite 
was used in the reaction. After 3 hours, the reactions were quenched with a 1:1 mixture of acetonitrile 
and water. Once quenched, the reactions were centrifuged in a tabletop centrifuge at maximum speed 
for 30 minutes, and 20 μL of supernatant was analyzed by LC-MS. 
 
Within the assay, the sodium phosphite provided the chemical energy for the product formation (Figure 
4). The enzyme PTDH transforms phosphite into phosphate, making NADH in the process. This NADH is 
subsequently consumed by RebF, a flavin reductase, when it turns FAD+ into FADH2. The FADH2 powers 
the halogenase reaction. The entire enzymatic sequence is regenerated in situ, only consuming 
phosphite ion, which is provided in excess. The procedure is similar to previously described assays, 
differing mainly in source of flavin reductase (13). 
 
Analysis of halogenated reaction products 
 
Reaction products were analyzed on an Agilent 1260 infinity quaternary LC coupled to impact II ToF 
mass spectrometer. Data was acquired in the positive mode between 100 and 2000 m/z. All procedures 
were identical to those previously described (13). Data was analyzed by MS1 (when available) and MS2. 
The formula for deconvoluted mass = (ion mass x charge) – (mass of hydrogen x charge) was used to find 
the deconvoluted mass of the whole peptide in MS1 (Figure 5A). For MS2 analysis, the 
phosphopantetheine ejection ion was used to determine halogenated product. The 
phosphopantetheine with the pyrrolyl substrate attached gives an ejection ion at 354.15 m/z. From that 
mass, any addition of halogen attachments increases the ejection ion mass to charge ratio (Figure 3). For 
chlorine, mono-chlorination results in a 388.11 m/z ejection ion, while di-chlorination results in an 
ejection ion at 422.07 m/z. Additionally, the 422.07 m/z ion exhibits an isotopic envelope effect 
characteristic of chlorination (Figure 6). For bromination, the ejection ions have exact masses of 432.06 
m/z (mono-bromination), 509.97 m/z (di-bromination), and 587.88 m/z (tri-bromination). 
 
Results and Discussion 
 
Synthesis of pyrrolyl-CP substrates 
 
Products of the reaction to generate pyrrolyl-CPs were analyzed with LC-MS. If the pyrrolyl-CP substrate 
was successfully generated, an ejection ion at 354.15 m/z should be observed. In the absence of the 
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pyrrolyl-pantetheine ejection ion, the predominant MS2 ion is the pantetheine ejection ion at 261.12 
m/z corresponding to the holo-CP (Figure 2A). The holo-CP is a result of the E. coli phospantetheinyl 
transferase attaching a pantetheine moiety to the CP during recombinant protein expression. Only a 
small fraction of the recombinant CP is transformed into holo-CP. Detection of pantetheine ejection ions 
of 354.15 m/z and 261.12 m/z from the pyrrolyl-CP synthesis reaction shows successful generation of 
pyrrolyl-CP substrate (Figure 2B). Only one representative example for Bmp1 (CP) and pyrrolyl-Bmp1 
(CP) is shown in Figure 2. Similar results hold true for pyrrolyl-PltL (CP), pyrrolyl-Clz18 (CP), and pyrrolyl-
Mpy15 (CP). 
 
Enzyme assay of CP with halogenase 
 
Assay with Pyrrolyl-Bmp1 (CP) and halogenase 
When assays were done to test the halogenase activity of Bmp2, PltA, and Mpy16 on pyrrolyl-Bmp1 (CP) 
substrate, none of the reactions showed evidence of halogenation, based on analysis of the MS1 spectra 
and the MS2 ejection ions (Figure 7). For the assay with Bmp2, the MS1 analysis of the [M+12H]+12 ion 
yielded a mass of 11,046 Da, which corresponds to the pyrrolyl-Bmp1 (CP) substrate. The MS2 for the 
assay with Bmp2 also yielded exclusively ejection ion at 354 m/z, with no ejection ions of 432, 510, or 
587 m/z, suggesting no halogenation reaction by Bmp2 (Figure 7A). The result is particularly concerning, 
as the Bmp1 and Bmp2 combination was meant to serve as a positive control. The reaction’s failure is 
likely due to Bmp2 having degraded activity during storage. PltA combined with pyrrolyl-Bmp1 (CP) gave 
a [M+12H]+12 ion with a monoisotopic mass of 921.5539, which corresponds to mass at 11,046 Da. This is 
the mass for the pyrrolyl-CP, the same as in the Bmp2 assay. When the MS2 spectrum was examined, it 
also gave no evidence of chlorination as ejection ions for chlorinated pyrrole were not detected and only 
ejection ions at 354 m/z were observed (Figure 7B). For the assay done with Mpy16 halogenase, 
pyrrolyl-Bmp1 (CP) showed a similar result as the [M+12H]+12 ion gave a mass of 11,046 Da, 
corresponding to the pyrrolyl substrate, with no MS2 evidence for halogenation (Figure 7D). The only 
halogenase that halogenated the pyrrolyl-Bmp1 (CP) substrate was Clz5, which showed a MS2 ejection 
ion for mono-chlorinated pyrrolyl-CP product (Figure 7C). However, the predominant MS2 ejection ion 
corresponded to the 354 m/z substrate suggesting low turnover of substrate by Clz5. 
 
Assay with Pyrrolyl-PltL (CP) and halogenase 
When pyrrolyl-PltL (CP) was used as a substrate with the various halogenases, every halogenase except 
Bmp2 resulted in a di-chlorinated product (Figure 8). Bmp2 once again showed no evidence of 
halogenation, with the only MS2 ejection ion 354 m/z (Figure 8A). The MS1 spectrum yielded a 
deconvoluted mass of 12,547 Da using the [M+15H]+15 ion, corresponding to the pyrrolyl-CP substrate. 
As expected, the assay with pyrrolyl-PltL (CP) substrate and PltA halogenase produced a di-chlorinated 
product shown by the MS2 ejection ion at 422 m/z (Figure 8B). The MS1 analysis was not possible due to 
very noisy data. The MS2 analysis of reaction product of halogenase Clz5 also resulted in 422 m/z 
ejection ion, showing the di-chlorination of pyrrolyl-PltL (CP) by Clz5 (Figure 8C). Similar to data from the 
PltA reaction, the MS1 data was too noisy to interpret. Finally, Mpy16 halogenase also showed di-
chlorination of pyrrolyl-PltL (CP) as evidenced by the MS2 data showing a strong ejection ion at 422 m/z 
(Figure 8D). 
 
Assay with Pyrrolyl-Mpy15 (CP) and halogenase 
For the assay with pyrrolyl-Mpy15 (CP) and halogenase, the activity varied among halogenases (Figure 
9). Bmp2 showed no evidence of halogenation, similar to the previous reactions with other CPs. The MS2 
spectrum showed a strong peak at 354 m/z but no peak that corresponded to either mono- or di-
bromination (Figure 9A). Furthermore, the MS1 data showed a [M+12H]+12 ion that gave a deconvoluted 
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mass of 10,681 Da, which corresponds to the pyrrolyl-Mpy15 (CP) substrate. The halogenase PltA mono- 
and di-chlorinated the pyrrolyl-Mpy15 (CP) substrate, as evidenced by the presence of 388 m/z and 422 
m/z MS2 peaks (Figure 9B). For the MS1 data, the predominant [M+11]+11 ion gave a deconvoluted mass 
of 10,749 Da, which is 68 Da higher than the pyrrolyl-Mpy15 (CP) observed in the Bmp2 assay. The shift 
in mass can be explained by the exchange of two hydrogen atoms for two chlorine atoms, which should 
result in a 67.9 Da shift. This result shows that the predominant reaction product of PltA is di-
chlorinated pyrrolyl-Mpy15 (CP). For Clz5, chlorinated product formation was less pronounced but still 
present (Figure 9C). The MS1 analysis of the predominant [M+11H]+11 ion gave a deconvoluted mass of 
10,681 Da, once again corresponding to the pyrrolyl-Mpy15 (CP) substrate. However, analysis of the MS2 
data shows ejection ions of 388 m/z and 354 m/z. This shows that Clz5 mono-chlorinates pyrrolyl-Mpy15 
(CP), but no evidence of di-chlorination was found. Mpy16 assayed with its native CP, pyrrolyl-Mpy15, 
did chlorinate the substrate, showing evidence of both mono- and di-chlorination. MS1 analysis of the 
most prominent peak (the [M+11H]+11 ion) gave a deconvoluted mass of 10,715 Da, which is a 34 Da 
mass change indicative of mono-chlorination. Consistent with this, the highest intensity ion in the MS2 
data was the 388 m/z ion along with 422 m/z and 354 m/z, corresponding to di-chlorinated product and 
pyrrolyl substrates respectively (Figure 9D). This result shows that Mpy16 can both mono- and di-




The results of the enzyme assays clearly show that halogenases can recognize pyrrolyl-CPs from across 
pathways and halogenate when analyzed by in vitro assays. The assays that showed no evidence of 
halogenation were mostly those involving Bmp2 as a halogenase, which could be explained by the 
specific preparation of Bmp2 used having lost its activity. The other assays that did not give evidence for 
halogenation were PltA with pyrrolyl-Bmp1 (CP) and Mpy16 with pyrrolyl-Bmp1 (CP). These enzymes in 
reaction showed chlorination activity, suggesting the observed result is not due to degradation of their 
activity. The selectivity that these enzymes display on pyrrolyl-CP substrate could be explained by 
protein-protein interactions between substrate and halogenase pair. It is possible that the CP and the 
halogenase must be in close proximity for their activity. Thus, there are likely to be motifs on both 
surfaces that facilitate interaction. The selectivity observed could be due to difference in amino acid 
residues between CP and halogenase pairs from different pathways. If some of these residues are 
different from species to species, it could lead to the selectivity that was observed.  
 
One way to understand the protein-protein interaction between the halogenase and CP pairs is to 
crystallize them in complex and study the structure-function relationship between the two proteins. A 
similar strategy has recently been employed to determine the complex of a CP and an oxidase enzyme in 
the tetrabromopyrrole biosynthetic pathway (14). Such a crystal structure would provide a framework 
for visualizing the differences in amino acid sequence for each CP. In follow up to that, site mutagenesis 
experiments could be performed to validate information obtained from the structure of the CP and 
halogenase pairs complex. 
 
This study of CP and halogenase selectivity has potential impacts in the pharmaceutical biosynthesis of 
halogenated molecules. Oftentimes, pharmaceuticals of interest have complicated chemical syntheses 
that can make it desirable to pursue a biosynthetic approach. By determining the selectivity of these CPs 
to related halogenase enzymes, we will be able to mix and match CP and halogenase pairs across 
pathways to obtain a designer natural product. Additionally, the results show that CPs and halogenases 
work together across a broad variety of bacterial sources.  
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Figure 1: Generalized biosynthetic pathway for halogenated pyrrole biosynthesis, with final products 
chlorizidine A, tetrabromopyrrole, marinopyrrole A, and pyoluteorin shown. The proline starting 
molecule is attached to the carrier protein using ATP and an adenylation domain. Once attached, the 
proline is dehydrogenated, then halogenated by the halogenase. The reaction highlighted with the red 
box is the main reaction that this study focuses on, involving the carrier protein with the halogenase. 
Once halogenated, the pathways diverge and utilize unique enzymes to form the final products shown 









Figure 2: Comparison of MS2 spectrum of Bmp1 (CP) and pyrrolyl-Bmp1 (CP). The 354.15 m/z ejection 
ion indicates the presence of the pyrrolyl-pantetheine group. Panel A shows the MS2 ejection ion at 
261.12 m/z of holo-CP protein. The holo-CP is evident at 261.12 m/z, while the apo-CP has no MS2 
ejection ion. Panel B shows the MS2 spectrum of the pyrrolyl-CP, with the characteristic ejection ion at 
354.15 m/z and 261.12 m/z in the CP protein generated from pyrrolyl-CP synthesis reaction. Since the 
holo-CP cannot react in the substrate synthesis reaction in this study, the 261.12 m/z peak is present in 
the pyrrolyl-CP spectrum as well. Panel C shows the structures of the apo-, holo-, and pyrrolyl-CPs and 




Figure 3: The enzymatic logic of product formation, along with the ejection ions indicative of each 
halogenation state. The pyrrolyl substrate was attached to the CP chemically. Reactions were monitored 
by looking for MS2 ion fragments corresponding to each halogenation state. The 354.15 m/z ion shows 
that halogenation has not taken place, while the chlorinated and brominated MS2 fragments each show 






Figure 4: Reaction scheme for enzymatic assays. The pyrrolyl CP was acted on by the halogenase, which 
requires FADH2 as a cofactor, as well as a source of halide ion. The FADH2 is regenerated in situ by flavin 
reductase RebF, which itself is powered by NADH. NADH is regenerated from NAD+ by the phosphite 






Figure 5: Representative MS spectra used for analyzing halogenation state. Shown here is the reaction 
product from the assay done with pyrrolyl-Bmp1 (CP) and Bmp2 halogenase. A) The MS1 data shows a 
peak at 921.9731 m/z that corresponds to a [M+12H]+12 ion. Using the formula mass = (monoisotopic 
mass x z) – (z x mass of H+), the mass of the CP was determined to be 11,046.59 Da, which is the mass of 
the pyrrolyl-Bmp1 (CP) substrate. B) The MS2 spectrum from the pyrrolyl-Bmp1 (CP) parent ion shows 
that the phosphopantetheine arm is not halogenated. Its 354 m/z corresponds to the pyrrole substrate, 




Figure 6: Representative MS2 ion showing isotopic signatures of mono- and di-chlorinated species from 
the reaction of pyrrolyl-Mpy15 (CP) with PltA halogenase. The 388 m/z ion (A) corresponds to the 































Figure 7: MS2 spectra from the reaction of pyrrolyl-Bmp1 (CP) with different halogenases. The MS2 data 
for each enzymatic reaction clearly shows the halogenation state of the products. Bmp2 (A), PltA (B), 
and Mpy16 (D) have peaks at 261 m/z (native phosphopantetheine ejection ion) and at 354 m/z (pyrrolyl 





Figure 8: MS2 spectra from the reaction of pyrrolyl-PltL (CP) with different halogenases. Bmp2 (A) 
showed no evidence of halogenation. Each of PltA, Clz5, and Mpy16 (B-D, respectively) di-chlorinated 




Figure 9: MS2 spectra from the reaction of pyrrolyl-Mpy15 (CP) with different halogenases. Bmp2 (A) 
showed no evidence of halogenation, while Clz5 produced a mono-chlorinated product (C). PltA (B) and 
Mpy16 (D) both led to formation of mono- and di-chlorinated products. 
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Table 1: Constructs used to express proteins used in this study. Each protein was expressed in E. coli 
BL21 cells. 
Construct Fusion Tag Plasmid Backbone Source Organism Reference 
Bmp1 N-terminal His6 pET-28b(+) M. mediterranea 
MMB-1 
(11) 
Bmp2 N-terminal His6 pET-28b(+) M. mediterranea 
MMB-1 
(11) 
PltL N-terminal His6 pET-28b(+) P. fluorescens Pf-5 (8) 
PltA N-terminal His6 pET-28b(+) P. fluorescens Pf-5 (8) 
Clz18 N-terminal His6 pET-28b(+) Streptomyces sp. 
CNH-287 
(9) 
Clz5 N-terminal His6 
with Maltose 
Binding Protein 
pET-28b(+) Streptomyces sp. 
CNH-287 
(9) 
Mpy15 N-terminal His6 pET-28b(+) Streptomyces sp. 
CNQ-418 
(10) 
Mpy16 N-terminal His6 
with MBP 
pET-28b(+) Streptomyces sp. 
CNQ-418 
(10) 
PtdH N-terminal His6 pET-15b(+) Pseudomonas 
stutzeri 
(15) 






Table 2: Buffer composition for protein purification.  
Buffer Name Composition 
Binding Buffer 20 mM Tris 
500 mM NaCl 
10% Glycerol 
pH 8 
Wash Buffer 20 mM Tris 
30 mM Imidazole 
1 M NaCl 
pH 8 
Elution Buffer 20 mM Tris 
250 mM Imidazole 
1 M NaCl 
pH 8 
Dialysis Buffer 20 mM Tris 
50 mM KCl 
pH 8.9 
IEX Buffer A 20 mM Tris 
pH 8.9 
IEX Buffer B 20 mM Tris 
1 M KCl 
pH 8.9 
Storage Buffer 20 mM HEPES 






Table 3: Reaction setup for synthesis of pyrrolyl-CPs. The pyrrolyl-pantetheine substrate is modified in 
situ by CoaA, CoaD, and CoaE to yield an acyl-CoA molecule. This acyl-CoA is then transferred to the CP 
by Sfp to form a pyrrolyl-CP. 
Component Final Concentration Function in assay 
HEPES pH 7.9 50 mM Buffer 
MgCl2 10 mM Cofactor 
Pyrrolyl-pantetheine 1 mM Reactant 
CoaA 1 μM Pantothenate kinase 
CoaD 1 μM Phosphopantetheine adenylyltransferase 
CoaE 1 μM Dephospho-CoA kinase 
Sfp 2 μM Phosphopantetheinyl transferase 
Purified CP 250 μM Substrate 
ATP 9 mM Chemical energy 




Table 4: Components of each enzymatic assay. The component, its function, and the final concentration 
is given. Each reaction had a total volume of 100 μL, adjusted to that exact volume with 25-60 μL of 20% 
glycerol. 
Component Final Concentration Function in Assay 
HEPES (pH 7.9) 20 mM Buffer 
KCl or KBr 200 mM Halide Source 
NAD+ 1 mM Cofactor 
FAD 100 μM Cofactor 
NaPhosphite 10 mM Chemical energy 
TCEP 5 mM Buffer 
Pyrrolyl-CP 50 μM Substrate 
Halogenase 20 μM Enzyme 
PTDH 10 μM Cofactor regeneration 
RebF 20 μM Cofactor regeneration 
20% Glycerol   Volume adjustment 
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